# Efficacy and Safety of AngongNiuhuang Pill in Patients With Acute Ischemic Stroke (ANGONG TRIAL)

Study · id `cardio:ct-nct04475328` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04475328](<https://clinicaltrials.gov/study/NCT04475328>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04475328

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

## Technical summary

Registry record NCT04475328. Randomized; double masking; primary purpose treatment. Start 2020-10-01 (actual); primary completion 2022-05-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 120 participants (enrolled count; ClinicalTrials.gov record NCT04475328, source copy `cardio:ctgov-nct04475328-2023-09-11`, retrieved 2026-10-26)
- Started: 2020-10-01 (actual) (ClinicalTrials.gov record NCT04475328, source copy `cardio:ctgov-nct04475328-2023-09-11`, retrieved 2026-10-26)
- Primary completion: 2022-05-01 (actual) (ClinicalTrials.gov record NCT04475328, source copy `cardio:ctgov-nct04475328-2023-09-11`, retrieved 2026-10-26)
- Completion: 2022-07-30 (actual) (ClinicalTrials.gov record NCT04475328, source copy `cardio:ctgov-nct04475328-2023-09-11`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04475328, source copy `cardio:ctgov-nct04475328-2023-09-11`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04475328-2023-09-11`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy and Safety of AngongNiuhuang Pill in Patients With Acute Ischemic Stroke (ANGONG TRIAL)
- Condition: Acute Ischemic Stroke
- Intervention (Drug): AngongNiuhuang pill
- Intervention (Drug): Placebo of AngongNiuhuang pill
- Intervention (Other): Standard treatment
- Lead sponsor: Peking Union Medical College Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Peking Union Medical College Hospital (`cardio:org-peking-union-medical-college-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Safety and efficacy of Angong Niuhuang Pills in patients with moderate-to-severe acute ischemic stroke (ANGONG TRIAL): A randomized double-blind placebo-controlled pilot clinical trial (`cardio:pubmed-39501831`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 43ab202cebb0ef3cb2863695fca1994ca5a8f8da752837a4ba704a3f48cf2e61
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
